In addition to its many medicinal uses, CBC has anti-inflammatory, anti-cancer, and neuroprotective properties. Research shows that it inhibits the growth of new cancer cells. However, it’s unknown whether it can kill cancer cells.
CBC inhibits the growth of new cancer cells
CBC, a non-psychoactive cannabinoid found in cannabis, has anti-inflammatory, analgesic, and anti-cancer properties. CBC also promotes bone growth, reduces inflammation, and has antibacterial and anti-inflammatory properties. It has been found to inhibit the development of new cancer cells in laboratory animals and humans. Its anti-cancer properties are essential for cancer patients who are undergoing chemotherapy.
CBC has also shown positive effects on neural stem progenitor cells, which are essential for healthy brain function. In experiments, CBC-treated neural stem progenitor cells became more viable and differentiated into glial cells, necessary for maintaining brain homeostasis. Among other parts, astrocytes direct neurotransmitters and counteract toxicity and inflammation.
It blocks pain and inflammation
Cannabichromene is the third most prevalent cannabinoid in cannabis and is an anti-inflammatory and analgesic. It is weaker than THC but exhibits similar analgesic and anti-erythroid activities. While the effect on pain is identical, cannabichromene inhibits GABA uptake more strongly than THC. This suggests that cannabidiol may have a more significant analgesic effect than THC.
Cannabinoids act by activating receptors on cells in the central nervous system (CNS) and immune cells. They may also contribute to the analgesic and anti-inflammatory effects of cannabis. They are divided into three major groups according to their sources and origin.
It has antidepressant properties
Cannabinoids are known to have antidepressant properties. However, cannabichromene has not been extensively studied for its antidepressant properties. However, it has been shown to decrease immobility time in mice. The study was conducted using the FST (fascistic state-dependent test), one of the most widely used animal models for evaluating the potential antidepressant-like activity of pharmaceutical drugs.
Researchers have discovered that cannabichromene can act like an antidepressant, which helps fight depression. The compound has been shown to work with THC and CBD, two other cannabinoids known for their antidepressant properties. The CBC compound also works with the endocannabinoid system, which is responsible for mood elevation.
While cannabichromene does not bind directly to cannabinoid receptors like THC or CBD, it has been shown to be beneficial for many patients. The substance stimulates the body to produce its endocannabinoids. It may also be useful in treating pain and inflammation.
It has neuroprotective properties
Cannabichromene CBC has several beneficial effects on the brain and nervous system. These include neuroprotective properties in many cases, including multiple sclerosis, an autoimmune disease characterized by damaged insulating membranes on nerve cells. This disease can lead to various problems, including muscle weakness and double vision. Patients with multiple sclerosis may benefit from cannabis-derived medicines, which decrease spasticity and neuropathic pain.
Cannabichromene is a component of the cannabis plant that has neuroprotective effects in preclinical studies. It is not known how the neuroprotective effect of cannabichromene is mediated. However, other phytocannabinoids, including CBD and D9-THC, may also exert neuroprotective effects.
Several other phytocannabinoids, including cannabidiol, are known for their neuroprotective properties. However, these compounds are expensive and difficult to find commercially. They also could be more stable.